Dabigatran Etexilate 43598-0642-60
- Manufacturer
- Dr.reddys Laboratories Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 28, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA208048
Need to source Dabigatran Etexilate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabigatran Etexilate Mesylate | 75 mg/1 |
Drug Class
Direct Thrombin Inhibitor [EPC]Thrombin Inhibitors [MoA]
Selected Package
43598-0642-60Selected60 CAPSULE in 1 BOTTLE (43598-642-60)